466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies
I.M. Quetglas, Roser Pinyol, Daniel Dauch, Anna Portela, Alberto Villanueva, Judit Peix, María Ángeles Moreno de la Higuera, Agrin Moeini, Jessica Zucman‐Rossi, Manel Esteller, Vincenzo Mazzaferro, Lars Zender, Josep M. Llovet (2014). 466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies. European Journal of Cancer, 50, pp. 152-152, DOI: 10.1016/s0959-8049(14)70592-1.